Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades8
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)
26 Mar 2019 - Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)
26 Mar 2019 - Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients
21 Feb 2019 - Faron Pharmaceuticals shares surge on latest Clevegen data
21 Feb 2019 - Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result
13 Feb 2019 - Faron Pharmaceuticals pins some hope to YODA trial
19 Dec 2018 - Dosing begins in Faron's study of 'Clevegen' drug
14 Dec 2018 - WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry
5 Dec 2018
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)
LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced ear...
Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)
LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday said it expects further disappointing results from Traumakine, as it plans a sh...
Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients
LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in F...
Faron Pharmaceuticals shares surge on latest Clevegen data
(Sharecast News) - Shares in Faron Pharmaceuticals were surging on Thursday morning, after it announced an update on early observations on immunity an...
Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result
LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said new data supports the use of Clever-1 antibodies in re-activating an immune respo...
Faron Pharmaceuticals pins some hope to YODA trial
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals issued interim results from its pharmacokinetic/dynamic 'YODA' study...
Dosing begins in Faron's study of 'Clevegen' drug
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Friday that the first patient has successfully been dos...
WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2...
Follow the stocks
